SLC6A5

Chr 11ADAR

solute carrier family 6 member 5

Also known as: GLYT-2, GLYT2, HKPX3, NET1

This gene encodes a sodium- and chloride-dependent glycine neurotransmitter transporter. This integral membrane glycoprotein is responsible for the clearance of extracellular glycine during glycine-mediated neurotransmission. This protein is found in glycinergic axons and maintains a high presynaptic pool of neurotransmitter at glycinergic synapses. Mutations in this gene cause hyperekplexia; a heterogenous neurological disorder characterized by exaggerated startle responses and neonatal apnea. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2016]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismAD/ARLOEUF 0.971 OMIM phenotype
Clinical SummarySLC6A5
🧬
Gene-Disease Validity (ClinGen)
hyperekplexia 3 · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
73 unique Pathogenic / Likely Pathogenic· 351 VUS of 892 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available
📖
GeneReview available — SLC6A5
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.97LOEUF
pLI 0.000
Z-score 1.72
OE 0.71 (0.520.97)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
-0.09Z-score
OE missense 1.01 (0.941.10)
442 obs / 436.5 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.71 (0.520.97)
00.351.4
Missense OE?1.01 (0.941.10)
00.61.4
Synonymous OE?1.19
01.21.6
LoF obs/exp: 28 / 39.7Missense obs/exp: 442 / 436.5Syn Z: -1.99
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveSLC6A5-related hyperekplexiaLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.75top 25%
GOF
0.82top 10%
LOF
0.2970th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Literature Evidence

DNIn vitro functional expression studies showed that S510R formed intracellular aggregates, abolished glycine uptake, and caused a dominant-negative effect.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

References

  1. 1.PMID 16751771

ClinVar Variant Classifications

892 submitted variants in ClinVar

Classification Summary

Pathogenic42
Likely Pathogenic31
VUS351
Likely Benign365
Benign78
Conflicting25
42
Pathogenic
31
Likely Pathogenic
351
VUS
365
Likely Benign
78
Benign
25
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
30
6
6
0
42
Likely Pathogenic
21
9
1
0
31
VUS
5
323
21
2
351
Likely Benign
0
13
116
236
365
Benign
0
10
56
12
78
Conflicting
25
Total56361200250892

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

13 pathogenic / likely-pathogenic (of 19) ClinVar copy-number / structural variants overlap SLC6A5 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

SLC6A5 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.